Thus, we hypothesized that JAK/STAT activation may contribute to the pathophysiology of septic shock and, given the lack of specific therapies for sepsis-induced MOF, that baricitinib may be a potential treatment (34). This evidence concerns the gene SOAT1 and Sepsis.